tiprankstipranks
Trending News
More News >
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market
Advertisement

RedHill Biopharma (RDHL) Income Statement

Compare
847 Followers

RedHill Biopharma Income Statement

Last quarter (Q2 2023), RedHill Biopharma's total revenue was $1.80M, a decrease of -90.21% from the same quarter last year. In Q2, RedHill Biopharma's net income was $761.00K. See RedHill Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 8.04M$ 6.51M$ 61.80M$ 85.76M$ 64.36M
Gross Profit
$ 4.85M$ 3.05M$ 28.46M$ 36.35M$ 27.47M
Operating Expenses
$ 19.46M$ -9.56M$ 71.31M$ 117.49M$ 91.15M
Depreciation and Amortization
$ 619.00K$ 1.99M$ 8.12M$ 18.16M$ 8.81M
EBITDA
$ -7.59M$ 26.27M$ -42.84M$ -63.03M$ -54.94M
Operating Income
$ -14.61M$ 12.63M$ -42.84M$ -81.14M$ -63.68M
Other Income/Expenses
$ 6.34M$ 11.32M$ -28.82M$ -16.61M$ -12.49M
Pretax Income
$ -8.27M$ 23.95M$ -71.67M$ -97.74M$ -76.17M
Net Income
$ -8.27M$ 23.92M$ -71.67M$ -97.74M$ -76.17M
Per Share Metrics
Basic EPS
$ -3.00$ 46.00$ -600.00$ -1.00K$ -1.00K
Diluted EPS
$ -3.00$ 46.00$ -600.00$ -1.00K$ -1.00K
Weighted Average Shares Outstanding
2.46M 518.24K 123.86K 93.05K 72.85K
Weighted Average Shares Outstanding (Diluted)
2.46M 518.24K 123.86K 93.05K 72.85K
Currency in USD

RedHill Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis